LIGAND PHARMACEUTICALS INCORPORATED Income (Loss) from Continuing Operations, Per Diluted Share
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Income (Loss) from Continuing Operations, Per Diluted Share of $6.13 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per diluted share for the quarter ending 2024-09-30 was -$0.39.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per diluted share for the quarter ending 2024-06-30 was -$2.88, a 2315.38% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per diluted share for the quarter ending 2024-03-31 was $4.75, a 95.47% increase year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per diluted share for the quarter ending 2023-09-30 was -$0.59, a 205.36% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per diluted share for fiscal 2025 was $6.13.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per diluted share for fiscal 2024 was -$0.22, a 107.26% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per diluted share for fiscal 2023 was $3.03.
- LIGAND PHARMACEUTICALS INCORPORATED income (loss) from continuing operations, per diluted share for fiscal 2022 was -$0.31, a 107.00% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $6.13 10-K · filed 2026-02-27 | ||||||
| 2024-12-31 | -$0.22 10-K · filed 2026-02-27 | ||||||
| 2024-09-30 | -$0.39 10-Q · filed 2024-11-08 | $1.46 10-Q · filed 2024-11-08 | |||||
| 2024-06-30 | -$2.88 10-Q · filed 2024-08-07 | $1.87 10-Q · filed 2024-08-07 | |||||
| 2024-03-31 | $4.75 10-Q · filed 2024-05-08 | ||||||
| 2023-12-31 | $3.03 10-K · filed 2026-02-27 | ||||||
| 2023-09-30 | -$0.59 10-Q · filed 2024-11-08 | $2.00 10-Q · filed 2024-11-08 | |||||
| 2023-06-30 | $0.13 10-Q · filed 2024-08-07 | $2.57 10-Q · filed 2024-08-07 | |||||
| 2023-03-31 | $2.43 10-Q · filed 2024-05-08 | ||||||
| 2022-12-31 | -$0.86 10-K · filed 2023-02-28 | -$0.31 10-K · filed 2025-02-28 | |||||
| 2022-09-30 | $0.56 10-Q · filed 2023-11-09 | $0.57 10-K · filed 2023-02-28 | $0.54 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | $0.74 10-Q · filed 2023-08-09 | $0.75 10-K · filed 2023-02-28 | -$0.02 10-Q · filed 2023-08-09 | ||||
| 2022-03-31 | -$0.77 10-Q · filed 2023-05-08 | ||||||
| 2021-12-31 | -$0.19 10-K · filed 2023-02-28 | $4.43 10-K · filed 2024-02-29 | |||||
| 2021-09-30 | $1.19 10-K · filed 2023-02-28 | ||||||
| 2021-06-30 | $2.12 10-K · filed 2023-02-28 | ||||||
| 2021-03-31 | $1.32 10-K · filed 2023-02-28 | ||||||
| 2020-12-31 | $0.39 10-K · filed 2023-02-28 | ||||||
| 2018-12-31 | $5.96 10-K · filed 2019-02-28 | ||||||
| 2017-12-31 | $0.53 10-K · filed 2019-02-28 | ||||||
| 2017-09-30 | $0.36 10-Q · filed 2017-11-09 | $0.84 10-Q · filed 2017-11-09 | |||||
| 2017-06-30 | $0.26 10-Q · filed 2017-08-09 | $0.48 10-Q · filed 2017-08-09 | |||||
| 2017-03-31 | $0.22 10-Q · filed 2017-05-09 | ||||||
| 2016-12-31 | -$0.11 10-K · filed 2019-02-28 | ||||||
| 2016-09-30 | $0.05 10-Q · filed 2017-11-09 | $0.03 10-Q · filed 2017-11-09 | |||||
| 2016-06-30 | -$0.30 10-Q · filed 2017-08-09 | -$0.28 10-Q · filed 2016-08-04 | -$0.01 10-Q · filed 2017-08-09 | $0.01 10-Q · filed 2016-08-04 | |||
| 2016-03-31 | $0.26 10-Q · filed 2017-05-09 | ||||||
| 2015-12-31 | $10.83 10-K · filed 2018-03-01 | $12.12 10-K · filed 2016-02-26 | |||||
| 2015-09-30 | $9.28 10-Q · filed 2016-11-14 | $10.58 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $1.11 10-Q · filed 2016-11-14 | $1.16 10-Q · filed 2016-11-14 | |||||
| 2015-03-31 | $0.04 10-Q · filed 2016-11-14 | ||||||
| 2014-12-31 | $0.34 10-K · filed 2015-02-23 | $0.09 10-K · filed 2014-12-01 | $0.56 10-K · filed 2017-02-28 | $0.43 10-K · filed 2014-12-01 | |||
| 2014-09-30 | $0.06 10-K · filed 2015-02-23 | $0.23 10-Q · filed 2014-10-31 | |||||
| 2014-06-30 | $0.07 10-K · filed 2015-02-23 | $0.17 10-Q · filed 2014-08-05 | |||||
| 2014-03-31 | $0.10 10-K · filed 2015-02-23 | ||||||
| 2013-12-31 | $0.09 10-K · filed 2015-02-23 | $0.43 10-K · filed 2016-11-14 | |||||
| 2013-09-30 | $0.09 10-K · filed 2015-02-23 | $0.33 10-Q · filed 2014-10-31 | |||||
| 2013-06-30 | $0.18 10-K · filed 2015-02-23 | $0.24 10-Q · filed 2014-08-05 | |||||
| 2013-03-31 | $0.06 10-K · filed 2015-02-23 | ||||||
| 2012-12-31 | -$0.14 10-K · filed 2015-02-23 | ||||||
| 2012-09-30 | -$0.01 10-Q · filed 2013-11-08 | -$0.27 10-Q · filed 2013-11-08 | |||||
| 2012-06-30 | -$0.22 10-Q · filed 2013-08-01 | -$0.26 10-Q · filed 2013-08-01 | |||||
| 2011-12-31 | $0.49 10-K/A · filed 2014-12-12 |